medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2019-17-226-234medsovet-4816Research ArticleШкола педиатраSchool for pediatricianВзгляд педиатра на лечение атопического дерматита с применением метилпреднизолонаPediatrician’s view about the treatment of atopic dermatitis with methylprednisolonehttps://orcid.org/0000-0001-8577-2330РоманюкФ. П.RomanyukF. P.

Романюк Федор Петрович, доктор медицинских наук, профессор, заведующий кафедрой педиатрии и неонатологии

191015, Санкт-Петербург, ул. Кирочная, д. 41

Fedor P. Romanyuk, Dr. of Sci. (Med.), Professor, Head of Chair for Pediatrics and Neonatology

41, Kirochnaya St., Saint-Petersburg, 191015

pitspb2004@mail.ruСеверо-Западный государственный медицинский университет имени И.И. МечниковаРоссияNorth-Western State Medical University named after I.I. MechnikovRussian Federation201924112019017226234Copyright © Романюк Ф.П., 20192019Романюк Ф.П.Romanyuk F.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/4816

Статья посвящена современному представлению об этиопатогенезе атопического дерматита у детей, на основании чего, с точки зрения врача-педиатра, принимается решение об эффективных современных лечебно-профилактических мероприятиях. Должное внимание отводится описанию высокоэффективных топических глюкокортикостероидов, позволяющих в короткие сроки достичь контроля над заболеванием. Среди всех топических кортикостероидов метилпреднизолона ацепонат 0,1%-ного местный глюкокортикостероид применяется у детей с 4 месяцев и имеет оптимальный безопасный терапевтический индекс, что продемонстрировано в рандомизированных исследованиях. В статье отражены принципы ведения больных детей с атопическим дерматитом, учитывающие широкий спектр коморбидных состояний и заболеваний.

The article considers the present-day idea of the etiopathogenesis of atopic dermatitis in children, which forms, from the pediatrician’s point of view, basis for decision making on effective modern therapeutic and preventive measures. Due attention is given to the description of highly effective topical glucocorticosteroids, which allows to gain control over the disease within a short time. Among all the topical corticosteroids of methylprednisolone aceponate 0.1%, local glucocorticosteroid can be used in children aged 4 months and older and has an optimal therapeutic index, safe, which is proved in the randomized trials. The article states the principles of management of sick children with atopic dermatitis, taking into account a wide range of comorbid conditions and diseases.

атопический дерматитдетитопические кортикостероидыметилпреднизолона ацепонаткоморбидные заболеванияАдвантанatopic dermatitischildrentopical corticosteroidsmethylprednisolone aceponatecomorbid diseasesAdvantanReferencesНамазова-Баранова: Л.С., Ганковская Л.В., Мешкова Р.Я. (ред.). Основы клинической иммунологии и аллергологии. М.: ПедиатрЪ, 2016. 152 с.Namazova-Baranova L.S., Gankovskaya L.V., Meshkova R.Ya. Fundamentals of Clinical Immunology and Allergology. Moscow: Pediatr = Pediatrician, 2016. 152 p. (In Russ.)Mahmoudi M. (ed.). Allergy and Asthma: The Basics to Best Practices. Springer; 2019:190-210. Available at: https://www.springer.com/gp/book/9783030051464.Mahmoudi M. (ed.). Allergy and Asthma: The Basics to Best Practices. Springer; 2019:190-210. Available at: https://www.springer.com/gp/book/9783030051464.Kliegman R.M., St. Geme J.W. III, Blum N.J., Shah S.S., Behrman R.E. Nelson textbook of pediatrics. 21 Edition. Philadelphia, PA: Elsevier; 2019:5006-5032. Available at: https://www.worldcat.org/title/nelson-textbook-of-pediatrics/oclc/1096283151.Kliegman R.M., St. Geme J.W. III, Blum N.J., Shah S.S., Behrman R.E. Nelson textbook of pediatrics. 21 Edition. Philadelphia, PA: Elsevier; 2019:5006-5032. Available at: https://www.worldcat.org/title/nelson-textbook-of-pediatrics/oclc/1096283151.Piteau Sh. (ed.). Update in Pediatrics. Springer; 2018:39-59. Available at: https://www.springer.com/gp/book/9783319580265#aboutBook.Piteau Sh. (ed.). Update in Pediatrics. Springer; 2018:39-59. Available at: https://www.springer.com/gp/book/9783319580265#aboutBook.Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483-94. doi: 10.1056/NEJMra074081.Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483-94. doi: 10.1056/NEJMra074081.Bieber T. Atopic dermatitis. Ann Dermatol. 2010;(22):125-137. doi: 10.5021/ad.2010.22.2.125.Bieber T. Atopic dermatitis. Ann Dermatol. 2010;(22):125-137. doi: 10.5021/ad.2010.22.2.125.Spergel J.M. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105(2):99-106; quiz107-9,117. doi: 10.1016/j.anai.2009.10.002.Spergel J.M. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105(2):99-106; quiz107-9,117. doi: 10.1016/j.anai.2009.10.002.Irvine A.D., McLean W.H.I., Leung D.Y.M. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315–1327. doi: 10.1056/NEJMra1011040.Irvine A.D., McLean W.H.I., Leung D.Y.M. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315–1327. doi: 10.1056/NEJMra1011040.Leung D.Y. Clinical implications of new mechanistic insights into atopic dermatitis. Curr Opin Pediatr. 2016;28(4):456–462. doi: 10.1097/MOP.0000000000000374.Leung D.Y. Clinical implications of new mechanistic insights into atopic dermatitis. Curr Opin Pediatr. 2016;28(4):456–462. doi: 10.1097/MOP.0000000000000374.Perry T.T., Pesek R.D. Clinical manifestations of food allergy. Pediatr Ann. 2013;42(6):e106-11. doi: 10.3928/00904481-20130522-09.Perry T.T., Pesek R.D. Clinical manifestations of food allergy. Pediatr Ann. 2013;42(6):e106-11. doi: 10.3928/00904481-20130522-09.Esaki H., Brunner P.M., Renert-Yuval Y., Czarnowicki T., Huynh T., Tran G., Lyon S., Rodriguez G., Immaneni S., Johnson D.B., Bauer B., Fuentes-Duculan J., Zheng X., Peng X., Estrada Y.D., Xu H., de Guzman Strong C., Suarez-Farinas M., Krueger J.G., Paller A.S., Guttman-Yassky E. Early-onset pediatric atopic dermatitis is TH 2, but also TH 17 polarized in skin. J Allergy Clin Immunol. 2016;138(6):1639–1651. doi: 10.1016/j.jaci.2016.07.013.Esaki H., Brunner P.M., Renert-Yuval Y., Czarnowicki T., Huynh T., Tran G., Lyon S., Rodriguez G., Immaneni S., Johnson D.B., Bauer B., Fuentes-Duculan J., Zheng X., Peng X., Estrada Y.D., Xu H., de Guzman Strong C., Suarez-Farinas M., Krueger J.G., Paller A.S., Guttman-Yassky E. Early-onset pediatric atopic dermatitis is TH 2, but also TH 17 polarized in skin. J Allergy Clin Immunol. 2016;138(6):1639–1651. doi: 10.1016/j.jaci.2016.07.013.Carson G.G., Rasmussen M.A., Thyssen J.P., Menne T., Bisgaard H. Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS One. 2012;(7):e48678. doi: 10.1371/journal.pone.0048678.Carson G.G., Rasmussen M.A., Thyssen J.P., Menne T., Bisgaard H. Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS One. 2012;(7):e48678. doi: 10.1371/journal.pone.0048678.Романюк Ф.П., Алферов В.П. Клиника и лечение атопического дерматита: пособие для врачей. СПб.: Астерион, 2014. 78 c.Romanyuk F.P., Alferov V.P. Clinic manifestation and treatment of atopic dermatitis: a guide for doctors. St. Petersburg: Asterion, 2014. 78 p. (In Russ.)Bantz S.K., Zhu Z., Zheng T. The atopic march:progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5(2):202. doi: 10.4172/21559899.1000202.Bantz S.K., Zhu Z., Zheng T. The atopic march:progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5(2):202. doi: 10.4172/2155-9899.1000202.Баранов А.А., Намазова-Баранова Л.С. (ред.) Атопический дерматит у детей. Клинические рекомендации для педиатров. М.: Педиатрь, 2017. 74 с.Baranov A.A., Namazova-Baranova L.S. Atopic dermatitis in children. Clinical guidelines for pediatricians. Moscow: Pediatr = Pediatrician; 2017. 74 p. (In Russ.)Sonneville K., Duggan Ch. Manual of Pediatric Nutrition. Fifth Edition. Peoples Medical Publishing House-USA; 2014. 635 c. Available at: https://ru.scribd.com/book/264088626/Manual-of-Pediatric-Nutrition-5e.Sonneville K., Duggan Ch. Manual of Pediatric Nutrition. Fifth Edition. Peoples Medical Publishing House-USA; 2014. 635 c. Available at: https://ru.scribd.com/book/264088626/Manual-of-Pediatric-Nutrition-5e.Schachner L.A., Hansen R.C. Pediatric Dermatology. Fourth Edition. Mosky Elsevier; 2011. 1786 c. Available at: https://www.elsevier.com/books/pediatric-dermatology/schachner/978-0-7234-3540-2.Schachner L.A., Hansen R.C. Pediatric Dermatology. Fourth Edition. Mosky Elsevier; 2011. 1786 c. Available at: https://www.elsevier.com/books/pediatric-dermatology/schachner/978-0-7234-3540-2.Eichenfield L.F., Tom W.L., Chamlin S.L., Feldman S.R., Hanifin J.M., Simpson E.L., et al. Guidelines of care for the management of atopic dermatitis. Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–351. doi: 10.1016/j.jaad.2013.10.010.Eichenfield L.F., Tom W.L., Chamlin S.L., Feldman S.R., Hanifin J.M., Simpson E.L., et al. Guidelines of care for the management of atopic dermatitis. Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–351. doi: 10.1016/j.jaad.2013.10.010.Simpson E.L., Chalmers J.R., Hanifin J.M., Thomas K.S., Cork M.J., McLean W.H.I., et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;(134):818–23. doi: 10.1016/j.jaci.2014.08.005.Simpson E.L., Chalmers J.R., Hanifin J.M., Thomas K.S., Cork M.J., McLean W.H.I., et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;(134):818–23. doi: 10.1016/j.jaci.2014.08.005.Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberger K., et al. Guidelines of care for the management of atopic dermatitis. Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116– 132. doi: 10.1016/j.jaad.2014.03.023.Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberger K., et al. Guidelines of care for the management of atopic dermatitis. Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116– 132. doi: 10.1016/j.jaad.2014.03.023.Левина Ю.Г., Алексеева А.А., Вишнева Е.А., Эфендиева К.Е., Томилова А.Ю. Особенности наружной терапии аллергического дерматита у детей: роль метилпреднизолона ацепоната. Педиатрическая фармакология. 2014;11(5):5258. doi: 10.15690/pf.v11i5.1165.Levina Y.G., Alekseeva A.A., Vishneva E.A., Efendieva K.E., Tomilova A.Y. Peculiarities of external therapy of atopic dermatitis in children: role of methylprednisolone aceponate. Pediatričeskaa farmakologia = Pediatric pharmacology. 2014;11(5):52-58. (In Russ.) doi: 10.15690/pf.v11i5.1165.Joo Sh., Kau A.L. (eds.). Allergy, Asthma, and Immunology Subspecialty Consult. The Washington Manual. Second Edition. Washington University School of Medicine; 2013. 205 c. Available at: https://www.worldcat.org/title/washington-manual-allergy-asthmaandimmunology-subspecialty-consult/oclc/713189757.Joo Sh., Kau A.L. (eds.). Allergy, Asthma, and Immunology Subspecialty Consult. The Washington Manual. Second Edition. Washington University School of Medicine; 2013. 205 c. Available at: https://www.worldcat.org/title/washington-manual-allergy-asthmaandimmunology-subspecialty-consult/oclc/713189757.Silverberg J.I., Nelson D.B., Yosipovitch G. Addressing treatment challenges in atopic dermatitis with novel topical therapies. J Dermatolog Treat. 2016;27(6):568-576. doi: 10.1080/09546634.2016.1174765.Silverberg J.I., Nelson D.B., Yosipovitch G. Addressing treatment challenges in atopic dermatitis with novel topical therapies. J Dermatolog Treat. 2016;27(6):568-576. doi: 10.1080/09546634.2016.1174765.Torrelo A. Methylprednisolone aceponate for atopic dermatitis. Int J Dermatol. 2017;56(6):691–697. doi: 10.1111/ijd.13485.Torrelo A. Methylprednisolone aceponate for atopic dermatitis. Int J Dermatol. 2017;56(6):691–697. doi: 10.1111/ijd.13485.Luger T.A. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol. 2011;25(3):251–258. doi: 10.1111/j.1468-3083.2010.03789.x.Luger T.A. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol. 2011;25(3):251–258. doi: 10.1111/j.1468-3083.2010.03789.x.Короткий Н.Г., Таганов А.В., Шимановский Н.Л. Опыт применения адвантана в лечении атопического дерматита у детей. Педиатрия. Журнал им. Г.Н. Сперанского. 2000;79(5):18. Режим доступа: https://cyberleninka.ru/article/n/opyt-primeneniya-advantana-metilprednizolonaatseponata-v-detskoy-dermatologicheskoypraktike-pri-lechenii-atopicheskogodermatita.Korotkiy N.G., Taganov A.V., Shimanovskiy N.L. Therapeutic experience in using Advantan to treat atopic dermatitis in children. Pediatriya = Pediatria. 2000;79(5):18. (In Russ.) Available at: https://cyberleninka.ru/article/n/opyt-primeneniyaadvantana-metilprednizolona-atseponatav-detskoy-dermatologicheskoy-praktikeprilechenii-atopicheskogo-dermatita.Niedner R., Zaumseil R.-P. Advantan® milk/ cream/ointment in children with atopic eczema and other dermatoses – an observational study in 558 children. (In German). Akt Dermatol. 2004;30(6):200–203. doi: 10.1055/s-2004-814472.Niedner R., Zaumseil R.-P. Advantan® milk/ cream/ointment in children with atopic eczema and other dermatoses – an observational study in 558 children. (In German). Akt Dermatol. 2004;30(6):200–203. doi: 10.1055/s-2004-814472.Schneider L., Tilles S., Lio P., Boguniewicz M., Beck L., Lebovidge J., Novak N., Bernstein D., Blessing-Moore J., Khan D., Lang D., Nicklas R., Oppenheimer J., Portnoy J., Randolph C., Schuller D., Spector S., Wallace D. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;(131):295–299. e1-27. doi: 10.1016/j.jaci.2012.12.672.Schneider L., Tilles S., Lio P., Boguniewicz M., Beck L., Lebovidge J., Novak N., Bernstein D., Blessing-Moore J., Khan D., Lang D., Nicklas R., Oppenheimer J., Portnoy J., Randolph C., Schuller D., Spector S., Wallace D. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;(131):295–299. e1-27. doi: 10.1016/j.jaci.2012.12.672.

The authors declare that there are no conflicts of interest present.